Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provides an update on the tradipitant development program.

An advocacy group criticizes Hims & Hers Health for allegedly misleading Super Bowl ad promoting weight loss products, violating FDA regulations. Read more here.

January 31, 2025. More for You ...

“You’ve gotta try this product,” Carlson said to Von, popping a mini-marshmallow-sized pouch into his mouth as the cameras started to roll. A sly grin spread across his face: “The truth is, Zyn is a ...

Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption ...

© 2025 NBCUniversal Media, LLCApple®, Apple logo® and App Store® are registered trademarks of Apple Inc.

Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts.

“You’ve gotta try this product,” Carlson said to Von, popping a mini-marshmallow-sized pouch into his mouth as the cameras started to roll. A sly grin spread across his face: “The truth is, Zyn is a ...

The White House launched a new cybersecurity safety label, the U.S. Cyber Trust Mark, intended to help consumers make informed decisions on smart device safety.

An archived copy of the webcast will be available for up to one year by visiting the “Investors & Media” section of the 4DMT website: https://ir.4dmoleculartherapeutics.com/events.